Younes M - Search Results

1

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A. Zheng B, et al. Among authors: younes a, younes m. Blood. 2003 Aug 1;102(3):1019-27. doi: 10.1182/blood-2002-11-3507. Epub 2003 Apr 10. Blood. 2003. PMID: 12689928 Free article.

2

Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death.

Georgakis GV, Li Y, Humphreys R, Andreeff M, O'Brien S, Younes M, Carbone A, Albert V, Younes A. Georgakis GV, et al. Among authors: younes a, younes m. Br J Haematol. 2005 Aug;130(4):501-10. doi: 10.1111/j.1365-2141.2005.05656.x. Br J Haematol. 2005. PMID: 16098063 Free article.

3

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

Fiumara P, Snell V, Li Y, Mukhopadhyay A, Younes M, Gillenwater AM, Cabanillas F, Aggarwal BB, Younes A. Fiumara P, et al. Among authors: younes a, younes m. Blood. 2001 Nov 1;98(9):2784-90. doi: 10.1182/blood.v98.9.2784. Blood. 2001. PMID: 11675352 Free article.

4

Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma.

Younes M, Georgakis GV, Rahmani M, Beer D, Younes A. Younes M, et al. Among authors: younes a. Eur J Cancer. 2006 Mar;42(4):542-7. doi: 10.1016/j.ejca.2005.11.013. Epub 2006 Jan 19. Eur J Cancer. 2006. PMID: 16426839

5

Receptor activator of nuclear factor kappaB (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia.

Yorke R, Younes A, Chirala M, Younes M. Yorke R, et al. Among authors: younes a, younes m. Eur J Cancer. 2003 Sep;39(14):2099-102. doi: 10.1016/s0959-8049(03)00434-9. Eur J Cancer. 2003. PMID: 12957466

6

Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.

Clodi K, Asgari Z, Younes M, Palmer JL, Cabanillas F, Carbone A, Andreeff M, Younes A. Clodi K, et al. Among authors: younes a, younes m. Cancer. 2002 Jan 1;94(1):1-5. doi: 10.1002/cncr.10164. Cancer. 2002. PMID: 11815953 Free article.

7

Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus.

Younes M, Schwartz MR, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Hum Pathol. 1999 Nov;30(11):1309-13. doi: 10.1016/s0046-8177(99)90061-8. Hum Pathol. 1999. PMID: 10571510

8

Estrogen receptor beta is expressed in human colorectal adenocarcinoma.

Witte D, Chirala M, Younes A, Li Y, Younes M. Witte D, et al. Among authors: younes a, younes m. Hum Pathol. 2001 Sep;32(9):940-4. doi: 10.1053/hupa.2001.27117. Hum Pathol. 2001. PMID: 11567223

9

Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus.

Younes M, Lechago J, Ertan A, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Hum Pathol. 2000 Apr;31(4):434-8. doi: 10.1053/hp.2000.6715. Hum Pathol. 2000. PMID: 10821489

10

Fas ligand expression in esophageal carcinomas and their lymph node metastases.

Younes M, Schwartz MR, Ertan A, Finnie D, Younes A. Younes M, et al. Among authors: younes a. Cancer. 2000 Feb 1;88(3):524-8. Cancer. 2000. PMID: 10649242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

892 results

Search Page

Filters